Market Tracker

01/19 5:15pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

124.83
Delayed Data
As of 4:00pm ET
 +0.84 / +0.68%
Today’s Change
35.98
Today|||52-Week Range
147.63
-1.75%
Year-to-Date

Today’s Trading

Previous close123.99
Today’s open124.75
Day’s range122.63 - 125.50
Volume883,830
Average volume (3 months)1,379,446
Market cap$12.3B
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-11.63%
Earnings growth (next 5 years)+163.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book11.70

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.91+1.62%
SGENSeattle Genetics Inc+0.03+0.06%
TSROTESARO Inc+0.41+0.65%
JAZZJazz Pharmaceuticals...-0.55-0.37%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)-$1.38
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts